12-51794600-GG-AA
Variant summary
The NM_001330260.2(SCN8A):c.4754_4755delinsAA (p.Trp1585Ter) variant causes a stop gained change. This is a loss-of-function variant that does not trigger NMD. Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 10.00). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001330260.2 stop_gained
Predictors
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 10 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PVS1Null variant in LOF gene | Non-NMD frameshift: ≥4 downstream pathogenic — very strong evidence preserved (PVS1); Stop-gained (exon 26 of 27) at amino acid 1585 of 1980; NMD not predicted. 103 pathogenic variants downstream support preserved loss-of-function impact. | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_001330260.2. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SCN8A | MANE Select | c.4754_4755delinsAA p.Trp1585Ter | stop_gained | Exon 26 of 27 | Prot: NP_001317189.1 | |
SCN8A | MANE Plus Clinical | c.4754_4755delinsAA p.Trp1585Ter | stop_gained | Exon 26 of 27 | Prot: NP_055006.1 | |
SCN8A | c.4631_4632delinsAA p.Trp1544Ter | stop_gained | Exon 25 of 26 | Prot: NP_001171455.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SCN8A | MANE Plus Clinical | c.4754_4755delinsAA p.Trp1585Ter | stop_gained | Exon 26 of 27 | Prot: ENSP00000346534 | |
SCN8A | MANE Select | c.4754_4755delinsAA p.Trp1585Ter | stop_gained | Exon 26 of 27 | Prot: ENSP00000487583 | |
SCN8A | TSL:1 | c.4631_4632delinsAA p.Trp1544Ter | stop_gained | Exon 24 of 25 | Prot: ENSP00000347255 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 2 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
PhyloP100 | Pathogenic | 10 |
Splicing Scores
No splicing scores have been computed for this variant.
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.